title: Red hot chilli consumption is harmful in patients operated for anal fissure - a randomized, double-blind, controlled study.
abstract: OBJECTIVE
  This study was aimed to determine whether there was any relationship between consumption of chillies and postoperative symptoms after closed anal sphincterotomy in patients with chronic anal fissure.
  
  
  METHODS
  Patients were randomly assigned to receive analgesics and fiber supplement alone (control patients) or consumption of 1.5 g chilli powder twice daily along with identical fiber and analgesics (chilli group). The evaluation of symptoms (pain, anal burning, and pruritus) during the postoperative period was assessed by means of patients' self-questionnaires. The amount of analgesic tablets consumed and the frequency of stool during the study period were also noted.
  
  
  RESULTS
  28 patients were recruited in each arm. Postoperative symptoms were higher in the group consuming chillies during the first postoperative week. The global scores for postoperative pain (7.60 in chilli group and 2.95 in control group, p < 0.001) and for anal burning (8.85 for the chilli group vs. 4.21 for the control group, p < 0.0001) were significant.
  
  
  CONCLUSIONS
  This study shows that consumption of red chillies after anal fissure surgery should be forbidden to avoid postoperative symptoms.
authors.affiliation: Fine Morning Hospital and Research Center, Laxminagar, Nagpur, India. drpjg_ngp@sancharnet.in
authors.forename: Pravin J
authors.initials: PJ
authors.lastname: Gupta
mesh_terms: D000293:Adolescent; D000328:Adult; D000700:Analgesics / Q000008:administration & dosage; D002211:Capsaicin / Q000009:adverse effects; D002212:Capsicum / Q000009:adverse effects* / Q000737:chemistry; D004311:Double-Blind Method; D005260:Female; D005401:Fissure in Ano / Q000601:surgery*; D006801:Humans; D008297:Male; D010149:Postoperative Pain / Q000139:chemically induced* / Q000188:drug therapy; D011538:Pruritus Ani / Q000139:chemically induced; D011795:Surveys and Questionnaires; D016896:Treatment Outcome